Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichi Node

Showing results (621-630 of 717) with videos related to

Pageof 72
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 11, 2021
Fasting Plasma Glucose and Incident Colorectal Cancer: Analysis of a Nationwide Epidemiological DatabaseHidetaka Itoh, Hidehiro Kaneko, Akira Okada, et al.
European Heart Journal Open|December 26, 2025
Sex differences in the progression of cardiovascular-kidney-metabolic syndromeSatoshi Taya, Kentaro Ejiri, Hidehiro Kaneko, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 22, 2026
In Response to "Quantifying the population burden of hypertension: methodological considerations on the PAF analysis of the DeSC cohort"Masachika Nishikawa, Yuta Suzuki, Hidehiro Kaneko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2022
Blood Pressure Classification Using the 2017 ACC/AHA Guideline and Heart Failure in Patients With CancerHidehiro Kaneko, Yuichiro Yano, Hokyou Lee, et al.
Heart and Vessels|December 25, 2015
Acute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: a message from SAMIT (Statin for Acute Myocardial Infarction Trial)Mitsuhiro Shimomura, Jun-Ichi Oyama, Masayoshi Takeuchi, et al.
Cardiovascular Diabetology|July 31, 2023
Rationale and design of an investigator-initiated, multicenter, prospective, placebo-controlled, double-blind, randomized trial to evaluate the effects of finerenone on vascular stiffness and cardiorenal biomarkers in type 2 diabetes and chronic kidney disease (FIVE-STAR)Atsushi Tanaka, Hirotaka Shibata, Takumi Imai, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 4, 2026
Population attributable fraction of modifiable risk factors for incident hypertension: an analysis of large-scale epidemiological cohortMasachika Nishikawa, Yuta Suzuki, Hidehiro Kaneko, et al.
The Journal of Nutrition|February 11, 2023
Threshold of BMI for the Development of Hypertension among Japanese AdultsYuta Suzuki, Hidehiro Kaneko, Yuichiro Yano, et al.
The Journal of Biological Chemistry|December 1, 2010
Mitochondrial dysfunction and increased reactive oxygen species impair insulin secretion in sphingomyelin synthase 1-null miceMasato Yano, Ken Watanabe, Tadashi Yamamoto, et al.
Journal of Diabetes Investigation|January 30, 2023
Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE studyDae Jung Kim, Wayne H-H Sheu, Wook-Jin Chung, et al.
Pageof 72

Showing results (621-630 of 717) with videos related to

Sort By:
Pageof 72
The Journal of Clinical Endocrinology and Metabolism|August 11, 2021
Fasting Plasma Glucose and Incident Colorectal Cancer: Analysis of a Nationwide Epidemiological DatabaseHidetaka Itoh, Hidehiro Kaneko, Akira Okada, et al.
European Heart Journal Open|December 26, 2025
Sex differences in the progression of cardiovascular-kidney-metabolic syndromeSatoshi Taya, Kentaro Ejiri, Hidehiro Kaneko, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 22, 2026
In Response to "Quantifying the population burden of hypertension: methodological considerations on the PAF analysis of the DeSC cohort"Masachika Nishikawa, Yuta Suzuki, Hidehiro Kaneko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2022
Blood Pressure Classification Using the 2017 ACC/AHA Guideline and Heart Failure in Patients With CancerHidehiro Kaneko, Yuichiro Yano, Hokyou Lee, et al.
Heart and Vessels|December 25, 2015
Acute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: a message from SAMIT (Statin for Acute Myocardial Infarction Trial)Mitsuhiro Shimomura, Jun-Ichi Oyama, Masayoshi Takeuchi, et al.
Cardiovascular Diabetology|July 31, 2023
Rationale and design of an investigator-initiated, multicenter, prospective, placebo-controlled, double-blind, randomized trial to evaluate the effects of finerenone on vascular stiffness and cardiorenal biomarkers in type 2 diabetes and chronic kidney disease (FIVE-STAR)Atsushi Tanaka, Hirotaka Shibata, Takumi Imai, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 4, 2026
Population attributable fraction of modifiable risk factors for incident hypertension: an analysis of large-scale epidemiological cohortMasachika Nishikawa, Yuta Suzuki, Hidehiro Kaneko, et al.
The Journal of Nutrition|February 11, 2023
Threshold of BMI for the Development of Hypertension among Japanese AdultsYuta Suzuki, Hidehiro Kaneko, Yuichiro Yano, et al.
The Journal of Biological Chemistry|December 1, 2010
Mitochondrial dysfunction and increased reactive oxygen species impair insulin secretion in sphingomyelin synthase 1-null miceMasato Yano, Ken Watanabe, Tadashi Yamamoto, et al.
Journal of Diabetes Investigation|January 30, 2023
Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE studyDae Jung Kim, Wayne H-H Sheu, Wook-Jin Chung, et al.
Pageof 72